Generic Product Showcase

Published Online: Monday, July 14, 2014
Follow Pharmacy_Times:

Lomedia 24 Fe

Marketed by: Amneal Pharmaceuticals
Compare to: Loestrin 24 Fe (Warner Chilcott)
Indication: Amneal Pharmaceuticals’ Lomedia 24 Fe is an
AB-rated generic equivalent to Warner Chilcott’s discontinued Loestrin 24 Fe. Lomedia 24 Fe contains norethindrone acetate and ethinyl estradiol 1 mg/20 mcg and ferrous fumarate 75 mg. It is indicated for prevention of pregnancy in women who elect to use oral contraceptives.
Dosage Form: Tablets: 1 mg/20 mcg, 75 mg
For More Information: www.amneal.com; Lomedia24fe.com





Doxycycline Capsules, USP
Manufactured by: Lupin Limited
Compare to: Monodox Capsules (Aqua Pharmaceuticals LLC)
Indication: Lupin Limited has received FDA approval to market doxycycline capsules, USP, 50 mg, 75 mg, and 100 mg, which are the AB-rated generic equivalent to Monodox Capsules, 50 mg, 75 mg, and 100 mg, by Aqua Pharmaceuticals, LLC.. Doxycycline capsules, USP, are indicated for the treatment of infections caused by various microorganisms, and as an adjunctive therapy in severe acne.
Dosage Form: Capsules: 50, 75, and 100 mg
For More Information: www.lupinpharmaceuticals.com





XULANE Transdermal System
Marketed by: Mylan Pharmaceuticals, Inc
Compare to: ORTHO EVRA (Janssen Pharmaceuticals Inc)
Indication: Mylan Pharmaceuticals, Inc, has launched XULANE (norelgestromin, ethinyl estradiol transdermal system), the generic version of Janssen Pharmaceuticals, Inc’s, ORTHO EVRA. Mylan received final approval from the FDA for its Abbreviated New Drug Application for this product. This product is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception.
Dosage Form: Transdermal patch: 150/35 mcg per day
For More Information: www.mylan.com





Valsartan Tablets
Manufactured by: Ohm Laboratories, Inc
Compare to: Diovan (Novartis)
Indication: Ohm Laboratories, Inc, a wholly owned subsidiary of Ranbaxy Laboratories, Limited, announced today that Ohm has received FDA approval to manufacture and market Valsartan 40-, 80-, 160-, and 320-mg tablets on an exclusive basis. Valsartan is the generic version of Novartis’ Diovan. It is indicated for the treatment of high blood pressure and heart failure.
Dosage Form: Tablets: 40, 80, 160, and 320 mg
For More Information: www.ranbaxy.com





Fenofibrate Tablets, Fenofibric Acid DR Capsules, Etodolac ER Tablets, Bupropion 300 mg ER Tablets, and Niacin ER Tablets
Marketed by: Zydus Pharmaceuticals
Since Zydus Pharmaceuticals’ first commercial launch in August 2005, it has grown steadily over the past 9 years and now offers more than 270 SKUs to the US market. Some of Zydus’ recent launches include fenofibrate tablets, fenofibric acid DR capsules, etodolac ER tablets, bupropion 300 mg ER tablets, and niacin ER tablets. Zydus is currently ranked number 8 in the leading corporations of unbranded generics in the US market based on dispensed prescriptions (IMS Health).
For More Information: www.zydususa.com


Related Articles
The FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of Novartis’ first-in-class secukinumab therapy for moderate-to-severe plaque psoriasis.
Secukinumab improved peripheral joint disease, prevented joint damage, and produced clear or almost clear skin in a pair of pivotal Phase 3 trials.
Latest Issues
$auto_registration$